---
layout: splash
title: 파마리서치 (214450)
excerpt: 파마리서치의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSDAQ
- Q:제약
keywords: 파마리서치, 214450
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 230,500 | <span style="color: tomato">1.8<small>%</small></span> | Q:제약 | 30.4 | 5.4 | 0.4<small>%</small> |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | Q:제약 / 의료용품 및 기타 의약 관련제품 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 재생의약품 |
| <span style="white-space:nowrap;">**상장**</span> | KOSDAQ / 2015년 7월 24일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 각자대표이사 강기석 각자대표이사 김신규 |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://pharmaresearch.co.kr](http://pharmaresearch.co.kr){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 10&#x2011;21 | | [결산실적공시예고              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20241021900434){:target="_blank"} |
| 10&#x2011;16 | | [임원ㆍ주요주주특정증권등소유상황보고서](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20241016000278){:target="_blank"} |
|  | | [주식등의대량보유상황보고서(일반)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20241016000272){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![214450](/stock/images/214450.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 230,500 | <span style="color: tomato">1.8<small>%</small></span> | <span style="color: tomato">2.4<small>%</small></span> | <span style="color: tomato">19.1<small>%</small></span> | <span style="color: tomato">63.1<small>%</small></span> | <span style="color: tomato">84.5<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: tomato">111.2<small>%</small></span> | 52.9<small>%</small> | 2.10 | -28.3<small>%</small> | -9.0<small>%</small> | -3.9 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| Q:제약 | 30.4 | 5.4 | 0.4<small>%</small> | - |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/214450/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=214450){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A214450&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=214450){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/214450){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/214450/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![214450](/stock/images/214450_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 111.2<small>%</small> | 52.9<small>%</small> | 2.10 | -28.3<small>%</small> | -9.0<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 83.0<small>%</small> | 52.1<small>%</small> | 1.59 | -23.3<small>%</small> | -8.2<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | 48.4<small>%</small> | 33.8<small>%</small> | 1.43 | -21.4<small>%</small> | -7.6<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | 14.2<small>%</small> | 40.5<small>%</small> | 0.35 | -29.9<small>%</small> | -13.9<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | 34.3<small>%</small> | 40.2<small>%</small> | 0.85 | -22.7<small>%</small> | -11.3<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | 75.4<small>%</small> | 42.1<small>%</small> | 1.79 | -21.5<small>%</small> | -4.6<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | 103.9<small>%</small> | 44.2<small>%</small> | 2.35 | -16.8<small>%</small> | -2.6<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | 58.4<small>%</small> | 47.1<small>%</small> | 1.24 | -28.3<small>%</small> | -14.8<small>%</small> |
| MACD[^fn_tech_metric_macd] | 40.6<small>%</small> | 34.4<small>%</small> | 1.18 | -13.8<small>%</small> | -7.3<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![214450](/stock/images/214450_corr.png){: .align-center}

|       | [클래시스](/214150/) | [한국콜마](/161890/) | [제이시스메디칼](/287410/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [브이티](/018290/) | [HD현대중공업](/329180/) | [삼양식품](/003230/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![214450](/stock/images/214450_2x.png){: .align-center}


> **관련 정보**

- [Q:제약 업종 목록](/stats/sector/kosdaq_업종_제약_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}